Tata 1mg Unicorn Acquired
Tata 1mg: Business Model Canvas
The nine-block Business Model Canvas, filled in only where a public source states it — empty blocks mean we haven't found a citable fact yet, not that the answer is zero.
Value Propositions
Mission to make healthcare 'understandable, accessible and affordable,' addressing a prior gap where health information in India was unavailable or incomprehensible.
sourceFirst Indian healthcare platform to earn LegitScript certification and ISO/IEC 27001:2022 certified for information security; free online doctor consultations and home sample collection.
sourceCustomer Segments
Consumers across 1,800+ Indian cities buying prescription/OTC medicines, booking lab tests, and seeking online doctor consultations.
sourceTata 1mg partners with corporates (via brokers such as Mahindra Insurance Brokers) to offer employee wellness programmes — 24x7 tele-doctor access, 1-1 counselling, and home sample collection — and partners with insurers for integrated digital healthcare benefits.
sourceCustomer Relationships
Strategic partnership designing customized wellness packages for corporates/employees/families: 24x7 tele-doctor access, 1-1 counselling, home sample collection, discounts on pharmacy and health check-ups.
sourceChannels
Primary digital storefront serving 1,800+ cities with 260M+ site visitors and 31M+ orders delivered.
sourceExpanded to 280+ physical stores across nine clusters as of FY26, with plans to grow to 500+ outlets within 12 months.
sourceKey Activities
Key Resources
Key Partnerships
March 2022 strategic investment (undisclosed sum) in radiology/digital diagnostics startup 5C Network to strengthen diagnostic capabilities.
sourceMay 2025 partnership integrating Unicommerce's SaaS technology to automate multi-channel order management and warehouse operations across 1,000+ Indian cities.
sourceRevenue Streams
Margin on medicine MRP; ePharmacy business reached breakeven in FY26.
sourceDiagnostics business crossed ₹600 crore in annual recurring revenue (ARR) with 40%+ YoY growth in FY26; historically diagnostics accounted for a large share of revenue.
sourceSpecialty Pharma division grew ~65% in FY26, driven by patient support programmes, adult vaccination, cancer care and obesity management.
sourceCost Structure
FAQs on Tata 1mg
What is Tata 1mg's business model?
Tata 1mg's core value proposition centers on Accessible, understandable, affordable healthcare, Certified, trusted platform.
How does Tata 1mg make money?
Tata 1mg's cited revenue streams include E-pharmacy (medicine sales), Diagnostics / lab testing, Specialty Pharma, Subscription plans.